Dow Down 0.13% Nasdaq Up 0.25%

Arena Pharmaceuticals, Inc. (ARNA)

-NasdaqGS
4.17 Up 0.05(1.13%) 10:59AM EDT - Nasdaq Real Time Price
Prev Close:4.12
Open:4.14
Bid:4.16 x 5200
Ask:4.17 x 3100
1y Target Est:7.06
Beta:-2.28
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.10 - 4.18
52wk Range:4.05 - 7.97
Volume:611,007
Avg Vol (3m):4,902,210
Market Cap:915.94M
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARNA

Comparison

Symbol% ChgMkt Cap
ARNAUp 1.13%915.94M
GSKUp 0.16%117.58B
OREXDown 0.09%701.51M
RHHBYDown 0.41%247.40B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Sep-14) :-0.12
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback